Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Kit for screening blood type irregular antibody

A kit and irregular technology, applied in the field of kits for screening irregular blood type antibodies, can solve problems such as delayed transfusion reactions, weak agglutination strength, endangering patients, etc., and achieve reduced clinical blood transfusion risk, good long-term stability, The effect of reducing batch-to-batch variation

Inactive Publication Date: 2017-09-26
SICHUAN MACCURA BIOTECH CO LTD
View PDF2 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Since the raw material of the irregular antibody screening kit is human red blood cells, its source is limited, so the antigen spectrum of irregular antibody screening red blood cells produced by different manufacturers is generally flawed, such as Rh, Kidd, Lewis and other blood group systems, most of which are not homozygous , but heterozygous, the homozygous gene encoding produces a double dose of the heterozygous gene, so using heterozygous red blood cells of these blood group systems to detect irregular antibodies may cause weak antibodies against these blood group systems due to dose effects Missed detection; and irregular antibody screening Kidd blood group system and Lewis blood group system on red blood cells have poor affinity with corresponding antibodies, and the agglutination strength is weak, which may also cause irregular antibody detection against Kidd blood group system and Lewis blood group system.
Antibodies against Rh, Kidd, Lewis and other blood group systems account for a relatively large proportion of all irregular antibodies, and most of them have clinical significance. If missed, it may cause more serious immediate or delayed transfusion reactions, endangering the patient's illness

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for screening blood type irregular antibody
  • Kit for screening blood type irregular antibody
  • Kit for screening blood type irregular antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1 Selection of O-type erythrocytes with broad antigen spectrum for 3 persons

[0037] It is composed of O-type red blood cells with suitable antigen spectrum ratio for 3 people. Each person's O-type red blood cells are divided into two branches, one is enzyme-treated red blood cells, and the other is not enzyme-treated red blood cells. Red blood cells for three persons are divided into No. Ⅰ, No. Ⅱ and No. Ⅲ groups. The three groups of red blood cells follow the following requirements:

[0038](1) The red blood cell antigen spectrum should include common clinically significant blood group system antigens (Rh, MNSs, Lewis, Kidd, Duffy, Kell, P). Red blood cells express D, C, c, E, e, Jk a 、Jk b , M, N, S, s, Fy a 、Fy b 、Le a 、Le b , K, k, P 1 and other antigens. D, C, c, E, e, s, Le in red blood cells per person b 、Fy a , K, at least two antigens are positive, M, N, S, Le a 、JK a 、JK b 、Fy b ,P 1 At least one antigen was positive.

[0039] (2) Hom...

Embodiment 2

[0044] Example 2 Effect of Enzyme Treatment Red Blood Cell System Test Conditions on Antibody Screening Test Results

[0045] In this embodiment, the quality control test: using the micro-column gel method, 50 μl of 1% red blood cell suspension treated under different conditions were added to the BIORAD diamed low-ion anti-human globulin card, and the test results were observed after centrifugation. Purpose: To detect whether red blood cells treated with different conditions will cause false positives.

[0046] Specificity test: Using the micro-column gel method, add 50 μl of 1% red blood cell suspension treated under different conditions to the BIORAD diamed low-ion anti-human globulin card, add 12 wells for the same type of cells; add 12 μl of the same type of cells Add commercialized blood group antibodies of known specificity to each well (anti-D, Anti-E, Anti-e, Anti-C, Anti-c, Anti-M, Anti-N purchased from Shanghai Blood, Anti-Jka, Anti-Jkb, Anti-P1, Anti-Lea, Anti-Leb)...

Embodiment 3

[0070] Embodiment 3 The method for determining the concentration of erythrocyte suspension in the erythrocyte detection system of the kit of the present invention

[0071] Randomly select 20 whole blood samples, measure their HCT (hematocrit) after mixing thoroughly, and prepare a red blood cell suspension with a concentration of 1% according to the HCT (hematocrit), and the solvent is normal saline. The hemoglobin content of the erythrocyte suspension was measured by the o-methylbenzidine method, and finally the true concentration of the cell suspension was deduced according to the amount of hemoglobin. The test results are shown in Table 5:

[0072] Table 5 prepares the deviation comparison of 1% erythrocyte suspension for traditional method and recommended method of the present invention

[0073]

[0074] According to the experimental data in the above table, it can be seen that the true concentration of the 1% red blood cell suspension prepared according to the traditi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a kit for screening a blood type irregular antibody, and belongs to the technical field of blood type antibody detection. The kit contains six parts of erythrocytes which are packaged separately and divided into three groups; the three groups of erythrocytes come from three persons respectively; at least two of D, C, c, E, e, s, Le, Fy and K antigens in the erythrocytes of each person are positive, and at least one of M, N, S, Le, JK, JK, Fy and P1 antigens is positive; antigen components of the three persons are complementary; each group of erythrocytes consists of two parts of independent erythrocytes packaged in the same specification; one part of erythrocytes is treated with bromelain, and the other part of erythrocytes is not treated with the bromelain; the concentrations of the six parts of erythrocytes in the kit are the same, and can be 1 to 5 percent. The kit is suitable for various blood type antibody detection methods in the prior art. By adopting the kit, the omission ratio of irregular antibodies is reduced, and the clinical blood transfusion risk is lowered.

Description

technical field [0001] The invention relates to the technical field of blood group antibody detection, in particular to a kit for screening blood group irregular antibodies which is applicable to various blood group antibody detection methods. Background technique [0002] In order to prevent the occurrence of various types of transfusion reactions or hemolytic disease of the newborn, it is very necessary to screen relevant blood donors and patients for irregular antibodies. Article 17 of the "Technical Standards for Clinical Blood Transfusion" of the Ministry of Health of my country stipulates that in case of any of the following situations, an antibody screening test must be carried out according to the relevant provisions of the "National Clinical Laboratory Operation Regulations": when the cross-matching blood is not suitable; for those with a history of blood transfusion, pregnancy history or Those who need to receive multiple blood transfusions in a short period of time...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/80
CPCG01N33/80
Inventor 毛亚琳王小波田君喜龙腾镶
Owner SICHUAN MACCURA BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products